Choice of neoadjuvant therapy for rectal cancer: simple chemotherapy or synchronous chemoradiotherapy / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
;
(12): 627-631, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-691341
ABSTRACT
Rectal cancer is one of the most common malignancies in China. Total mesorectal excision (TME) plus neoadjuvant therapy is the standard treatment for locally advanced rectal cancer. After a development of over 20 years, neoadjuvant synchronous chemoradiotherapy has become the standard treatment and cornerstone of neoadjuvant therapy for rectal cancer. However, radiotherapy does not really increase the overall survival and is associated with long-term impact on the functions of anus, sex, urinary system and fertility, so the application of simple neoadjuvant chemotherapy rises gradually and becomes a potentially better treatment option. This paper elaborates the reason, present research status and future trend of the rising neoadjuvant chemotherapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Neoplasias Retais
/
Terapêutica
/
China
/
Resultado do Tratamento
/
Terapia Neoadjuvante
/
Quimiorradioterapia
/
Estadiamento de Neoplasias
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Chinês
Revista:
Chinese Journal of Gastrointestinal Surgery
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS